Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Return on Sales (2021 - 2025)

Rxo's Return on Sales history spans 5 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales fell 2.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.02%, up 5.0%, while the annual FY2025 figure was 0.02%, 5.0% up from the prior year.
  • Return on Sales reached 0.03% in Q4 2025 per RXO's latest filing, down from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.04% in Q2 2022 to a low of 0.23% in Q3 2024.
  • Average Return on Sales over 5 years is 0.01%, with a median of 0.0% recorded in 2023.
  • Peak YoY movement for Return on Sales: decreased -23bps in 2024, then grew 22bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then plummeted by -111bps to 0.0% in 2022, then skyrocketed by 157bps to 0.0% in 2023, then tumbled by -833bps to 0.01% in 2024, then tumbled by -109bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for RXO's Return on Sales are 0.03% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).